The Neuroleptic Treatment of Schizophrenia: Dosing Strategies, Depot Preparations and Novel Medications

Authors

Alexander S. Young M.D., Research Fellow, Robert Wood Johnson Clinical Scholars Program, Departments of Medicine and Psychiatry, UCLA and West Los Angeles Veterans Affairs Medical Center, Los Angeles, California

Abstract

Significant progress has been made over the past decade in the use of antipsychotic medication. An improved understanding of neuroleptic side effects has led to the development of new clinical strategies for dosing traditional medications. Traditional medications have become widely used in depot preparations. Risperidone, a new medication with an improved side effect profile, has recently become available. Clozapine, a novel medication, has entered widespread use. The use of these new clinical technologies is briefly discussed, along with the implications they have for the role of the psychiatrist in community mental health settings.

Recommended Citation

Young, Alexander S. M.D. (1996) "The Neuroleptic Treatment of Schizophrenia: Dosing Strategies, Depot Preparations and Novel Medications," Jefferson Journal of Psychiatry: Vol. 13: Iss. 1, Article 4.
DOI: https://doi.org/10.29046/JJP.013.1.003
Available at: https://jdc.jefferson.edu/jeffjpsychiatry/vol13/iss1/4